Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUNGSTAR: Pravastatin with Chemotherapy in Small Cell Lung Cancer
NCT00433498Phase 3Completed
- Sponsor
- University College London
- Start
- Jan 2007
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in small cell lung cancer (SCLC) comparing Pravastatin + Chemo with Placebo + Chemo (2 arms). Primary endpoint: Overall Survival. Started Jan 2007; status: completed.
02
Drugs
pravastatin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00433498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433498.